Kailera Therapeutics Inc IPO unlock schedule & public float
Lock-up schedule, public float and locked shares extracted from Kailera Therapeutics Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Shares eligible to trade · by holder groupApr 17, 2026 → Oct 14, 2026 · 100% unlocked
Lock-up holders84.62M
IPO public float39.06M
Supply pressure · next 90 daysMedium
Up to 84.62M shares (~2.2× the current float) become eligible within 90 days. A meaningful slice of locked shares becomes eligible within 90 days.
About Kailera Therapeutics Inc
Kailera Therapeutics Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Kailera Therapeutics Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
Final prospectus
EDGAR filings resolved from KLRA / CIK 0002096997.
